New award for ramipril capsules with exelan pharmaceuticals INC. The period of performance is march 14, 2022 to march 13, 2023 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0010
Awardee
Awarding agency
Task orders
1 $1,686 obligated

Award facts

Opportunity
Combined order value
$1,686 Current and potential, with all options
Last date to order 92% complete
IDV ceiling <1% used
$12,802,166.10
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Ramipril Capsules with a ceiling of $12,802,166.10 on March 14, 2022. Performance runs from March 14, 2022 through March 13, 2023, with four one-year options extending the ultimate completion date to March 13, 2027. No set-aside was used. Work is performed at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary performance locations in Cary, North Carolina; Summit, New Jersey; and Ottawa, Ontario, Canada, as well as other designated federal delivery locations as specified by the contracting agency.

The originating solicitation, posted September 29, 2021 with a due date of October 13, 2021, sought supply of Ramipril Capsules for federal healthcare systems. NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals) apply.

Recent activity under this IDIQ includes a delivery order issued October 1, 2026 by Federal Correctional Institution Edgefield for flu vaccine supplies for inmates aged 65 and older, valued at $1,685.74 and due September 30, 2027, performed in Summit, New Jersey.

The contract incorporates implementation of Executive Order 14398 addressing DEI discrimination by federal contractors.

Task orders

Task order Ordering agency Obligated Awarded
Flu vaccine for inmates 65 and older 15B30326F00000035 Federal Correctional Institution Edgefield (BOP) $1,686

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00015 · Implementation of executive order 14398 addressing DEI discrimination by federal contractors $0
Add Subcontract Plan P00014 · Incorporate the 2026/2027 approved subcontracting plan $0
Exercise an Option P00013 · Exercise option year 4 with exelan pharmaceuticals for ramipril capsules. Period of performance is march 14, 2026 - march 13, 2027 with no price changes. $0
Add Subcontract Plan P00012 · To incorporate the 2025 approved subcontracting plan $0
Exercise an Option P00011 · Exercise option year three with exelan pharmaceuticals for ramipril capsules. Period of performance is 3/14/2025 - 3/13/2026. No price changes $0
Other Administrative Action P00010 · To incorporate a change in the administrative and sales point of contact for exelan pharmaceuticals, INC. $0
Add Subcontract Plan P00009 · To incorporate the 2024/2025 approved subcontracting plan $0
Supplemental Agreement for work within scope P00008 · Change timeframe for the submission of quarterly sales reports and cost recovery fee to 30 calendar days after end of each fiscal quarter. $0
Exercise an Option P00007 · Exercise option year two for ramipril capsules. Period of performance is 3/14/2024 through 3/13/2025. $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · To incorporate a change in the administrative and sales point of contact for exelan pharmaceuticals INC. $0
Other Administrative Action P00004 · Incorporation of drug supply chain security act (dscsa) language $0
Add Subcontract Plan P00003 · Incorporate 2023 small business subcontracting plan into contract. Plan is effective 4/1/2023 - 3/31/2024. $0
Exercise an Option P00002 · Exercise option year 1 effective march 14, 2023 to march 13, 2024 for ramipril capsules with exelan pharmaceuticals, INC. $0
Add Subcontract Plan P00001 · Incorporate the 2022 approved subk plan. Plan effective 4/1/2022 - 3/31/2023. $0
Original award $0
Show all 16

Quick answers

Who was awarded contract 36E79722D0010?

36E79722D0010 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on March 14, 2022.

How much is contract 36E79722D0010 worth?

Orders under 36E79722D0010 have obligated $1,686. 36E79722D0010's own ceiling is $12,802,166.

How many orders have been placed under contract 36E79722D0010?

1 order has been placed under 36E79722D0010, the latest on October 1, 2026.

Who can order from contract 36E79722D0010?

36E79722D0010 is a single award indefinite delivery contract.

Was contract 36E79722D0010 competed?

The extent of competition for 36E79722D0010 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV